Skip to content

The use of Gabapentin for neuralgia in facial fracture patients

The use of Gabapentin for neuralgia in facial fracture patients : A randomized controlled trial, double-blind, pilot study

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220222002
Enrollment
70
Registered
2022-02-22
Start date
2022-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic neuropathy from facial fracture Gabapentin, Neuropathy, Facial fracture, Sensory impairment, Pain intensity, Quality of life

Interventions

Received Gabapentin(300mg) 1 tab per oral twice a day for 3 months,Received Vitamin B 1 tab per oral twice a day for 3 months
Gabapentin,Vitamin B

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Traumatic facial fracture patient who in stable condition, 2. Numbness at fracture site, 3. First visit at facial fracture clinic within 2 weeks after injuries

Exclusion criteria

Exclusion criteria: 1. Who has other injuries that interfere assessment, 2. Who has Intellectual disability or Communication disability, 3. Who are pregnancy or lactation, 4. Who allergic to gabapentin, 5. Who is using Gabapentin, Carbamazepine, Amitriptyline, 6. Who is recieved surgery from the fracture, 7. End stage kidney disease (CrCl < 15 ml/min ), 8. Who has history of analgesic drus abuse

Design outcomes

Primary

MeasureTime frame
Neuropathy at 3 months after end of the intervention level of sensory impairment,Neuropathy at 3 months after end of the intervention pain intensity

Secondary

MeasureTime frame
Sensation at 3 months after end of the intervention Patient reported outcome using a questionnaire interview,adverse event at 3 months after end of the intervention Patient reported outcome using a questionnaire interview,discontinuation at 3 months after end of the intervention Patient reported outcome using a questionnaire interview,satisfaction at 3 months after end of the intervention Patient reported outcome using a questionnaire interview,quality of life at 3 months after end of the intervention Patient reported outcome using a questionnaire interview

Countries

Thailand

Contacts

Public ContactJatuporn Sirikun

Department of surgery, Faculty of medicine, Siriraj Hospital

j_sirikun@hotmail.com0241977279

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026